Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

19

Revenue 2017

Celgene

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Celgene's 2013 oncology sales performance.

Celgene

AbbVie enters BCMA race with Teneobio deal

AbbVie enters BCMA race with Teneobio deal

pipeline molecules.  Coming to the fore in this race are a group of BCMA-targeting CAR-T candidates from Bluebird Bio, Celgene/Juno and Johnson &Johnson/Legend Biotech.

Alector kicks off next wave of biotech IPOs

Alector kicks off next wave of biotech IPOs The company is led by Faheem Hasnain and Sheila Gujrathi, two former execs from Receptos - the company bought out by Celgene four years ago for $7.2bn.

Gilead awaits CEO and readouts to revive fortunes

Gilead awaits CEO and readouts to revive fortunes However, despite the recent $74bn mega-merger of BMS and Celgene, the mood in the sector looks to be towards bolt-on acquisitions which can create more long term value.

Sanofi's Darzalex rival scores in myeloma trial

Sanofi's Darzalex rival scores in myeloma trial Top-line results from the ICARIA-MM trial reveal that the CD38-targeting antibody was able to prolong progression-free survival (PFS) when added to a standard myeloma regimen of ... Celgene’s Revlimid (lenalidomide) and dexamethasone.

BMS isn’t phased by Opdivo’s slowing growth – for now

BMS isn’t phased by Opdivo’s slowing growth – for now The difficulties facing Opdivo help make the case for BMS’ decision to spend $74bn on a merger with Celgene – boosting its cancer and immunology portfolios – and the company spent a lot ... over Celgene’s top-seller Revlimid (lenalidomide), which

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....
Cutting through the noise
AstraZeneca looks to lead an R&D revolution as the company invests in CRISPR and functional genomics drug discovery...
International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...

Infographics